文献速递重症综合管理与镇静镇痛心脑血管急症呼吸衰竭与机械通气

流感疫苗接种与65岁及以上重症监护幸存者1年内心肌梗死、卒中、心力衰竭、肺炎及死亡风险:一项全国性人群队列研究

Influenza vaccination and 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and mortality among intensive care unit survivors aged 65 years or older: a nationwide population-based cohort study.
PubMed 文献 · Intensive Care Med · 2019-06-11
一句话结论≥65岁ICU幸存者接种流感疫苗与1年卒中风险(校正HR 0.84)及死亡风险(校正HR 0.92)降低相关,支持该人群接种流感疫苗。

该研究基于丹麦重症监护数据库2005—2015年全部≥65岁ICU住院并存活出院患者,链接其他医疗登记数据获取季节性流感疫苗接种信息,共纳入89,818例ICU幸存者。计算1年内因心肌梗死、卒中、心力衰竭、肺炎住院及全因死亡风险,采用Cox比例风险回归计算HR及95%CI,并通过调整和倾向性评分匹配控制混杂。接种组(n=34,871,39%)较未接种组年龄更大、慢性病更多、处方药使用更多;校正后1年死亡率接种组19.3% vs 未接种组18.8%(校正HR 0.92,95%CI 0.89-0.95),卒中校正HR 0.84(95%CI 0.78-0.92),心肌梗死校正HR 0.93(95%CI 0.83-1.03),心力衰竭和肺炎住院无关联。倾向性评分匹配分析证实上述结果,结论支持≥65岁个体接种流感疫苗。

要点

  • ≥65岁ICU幸存者接种流感疫苗与1年死亡风险降低相关:校正HR 0.92(95%CI 0.89-0.95),接种组1年死亡率19.3% vs 未接种组18.8%。
  • 接种流感疫苗与1年卒中风险降低相关:校正HR 0.84(95%CI 0.78-0.92)。
  • 接种流感疫苗与1年心肌梗死风险仅呈小幅、未达统计学显著的降低:校正HR 0.93(95%CI 0.83-1.03)。
  • 接种流感疫苗与1年因心力衰竭或肺炎住院无关联。
  • 倾向性评分匹配分析证实上述结果,作者结论支持≥65岁个体接种流感疫苗。

适用人群与场景

  • 2005—2015年丹麦所有≥65岁、在丹麦ICU住院并随后出院的患者,共89,818例ICU幸存者。
  • 接种组34,871例(39%),较未接种组年龄更大、慢性病更多、处方药使用更多。

研究设计与关键结果

  • 研究类型:全国性人群队列研究,纳入89,818例≥65岁ICU幸存者,比较接种与未接种季节性流感疫苗者1年内因心肌梗死、卒中、心力衰竭、肺炎住院及全因死亡风险。
  • 主要终点:校正后1年死亡率接种组19.3% vs 未接种组18.8%,校正HR 0.92(95%CI 0.89-0.95)。
  • 卒中:接种组较未接种组风险降低,校正HR 0.84(95%CI 0.78-0.92)。
  • 心肌梗死:校正HR 0.93(95%CI 0.83-1.03),仅小幅、未达统计学显著的降低。
  • 心力衰竭和肺炎住院:接种与未接种之间无关联。
  • 倾向性评分匹配分析证实上述 findings。

证据类型、等级与局限

  • 证据类型:全国性人群队列研究。
  • 采用Cox比例风险回归计算HR及95%CI,并通过调整和倾向性评分匹配控制混杂。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:研究结果支持≥65岁个体接种流感疫苗。
  • 对≥65岁ICU幸存者,接种流感疫苗与1年卒中风险(校正HR 0.84)和死亡风险(校正HR 0.92)降低相关,与心肌梗死、心力衰竭、肺炎住院无实质关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: We examined whether influenza vaccination affects 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and death among intensive care unit (ICU) survivors aged ≥ 65 years.

METHODS: Danish Intensive Care Database data on all elderly ( ≥ 65 years) patients hospitalized in Danish ICUs in the period 2005-2015, and subsequently discharged, were linked with data from other medical registries, including data on uptake of the seasonal influenza vaccine. We computed these patients' 1-year risk of hospitalization for myocardial infarction, stroke, heart failure, or pneumonia, and their 1-year risk of all-cause mortality. Hazard ratios (HRs) with 95% confidence intervals (CIs) were computed using Cox proportional hazards regression, with adjustment and propensity score matching applied to handle confounding.

RESULTS: The study included 89,818 ICU survivors. The influenza vaccinated patients (n = 34,871, 39%) were older, had more chronic diseases, and used more prescription medications than the unvaccinated patients. Adjusted 1-year mortality was decreased among the vaccinated versus the unvaccinated patients (19.3% versus 18.8%; adjusted HR, 0.92; 95% CI 0.89-0.95). Influenza vaccination was also associated with a decreased risk of stroke (adjusted HR, 0.84; 95% CI 0.78-0.92), but only a small, non-significantly decreased risk of myocardial infarction (adjusted HR, 0.93; 95% CI 0.83-1.03). There was no association between vaccination and subsequent hospitalization for heart failure or pneumonia. Propensity score matched analyses confirmed these findings.

CONCLUSIONS: Compared with the unvaccinated ICU survivors, the influenza vaccinated ICU survivors had a lower 1-year risk of stroke and a lower 1-year risk of death, whereas no substantial association was observed for the risk of hospitalization for myocardial infarction, heart failure, or pneumonia. Our findings support influenza vaccination of individuals aged ≥ 65 years.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Christiansen CF, Thomsen RW, Schmidt M, et al. Influenza vaccination and 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and mortality among intensive care unit survivors aged 65 years or older: a nationwide population-based cohort study. Intensive Care Med. 2019. PMID: 31187170. doi:10.1007/s00134-019-05648-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。